Stockreport

Artelo's stock soars after NCI grant to develop cancer treatment [MarketWatch]

Artelo Biosciences, Inc.  (ARTL) 
US:NASDAQ Investor Relations: artelobio.com/investors
PDF Artelo's stock soars after NCI grant to develop cancer treatment Shares of Artelo Biosciences Inc. ARTL, +35.95% shot up 44% in very active trading Monday, after the [Read more]